LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming November 30, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026 inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR ANAVEX LIFE SCIENCES CORP. INVESTMENTS, CLICK HERE TO INQUIRE A